CTOs on the Move

B C Decker

www.bcdecker.com

 
B C Decker Inc. is a Hamilton, ON-based company in the Healthcare, Pharmaceuticals, and Biotech sector.
  • Number of Employees: 0-25
  • Annual Revenue: $1-10 Million
  • www.bcdecker.com
  • 50 King St E 2nd Fl
    Hamilton, ON CAN L8N 1A6
  • Phone: 905.522.7017

Executives

Name Title Contact Details

Similar Companies

Jupiter Medical Center

Jupiter Medical Center offers you a spectrum of healthcare services, from emergency services and inpatient acute care, to our progressive Health and Rehabilitation Center and Wound Care Center.

Specialty Carts

Specialty Carts is a Saint Louis, MO-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

Willis-Knighton Health System

Willis-Knighton Health System is one of the leading companies in Healthcare, Pharmaceuticals, and Biotech industry. Willis-Knighton Health System is based in Shreveport, LA. You can find more information on Willis-Knighton Health System at www.wkhs.com

IOVATE Health Sciences Research

IOVATE Health Sciences Research, Inc. is one of the leading companies in Healthcare, Pharmaceuticals, and Biotech industry. IOVATE Health Sciences Research, Inc. is based in Oakville, ON. You can find more information on IOVATE Health Sciences Research, Inc. at www.iovate.com

Celator Pharmaceuticals

Celator Pharmaceuticals, Inc. is a clinical-stage biopharmaceutical company that is transforming the science of combination therapy and developing products to improve outcomes for patients with cancer. The Company is working to establish a new treatment paradigm in which rationally-designed, fully-integrated combination products replace combination regimens of individual agents. Celator`s proprietary technology platform, CombiPlex®, identifies the most effective synergistic ratio of the component drugs, optimizes the pharmacology of the drug combination prior to human clinical trials, allows simultaneous administration of the components as a single product and maintains the synergistic ratio of the components after administration thereby exposing tumor cells to the right amounts of drug for the right length of time.